6 Red Days In A Row: Albemarle Stock Is Down 15% | Trefis
📉 Albemarle (ALB) stock has fallen for six consecutive trading days, losing a cumulative 15% of its value.
💸 The recent price streak has erased approximately $2.3 billion from the company's total market capitalization.
📊 Revenue growth over the last twelve months reached 18.3%, significantly exceeding the 6.9% median for S&P 500 Materials peers.
⚖️ The company maintains an operating margin of 13.7%, which is slightly above the 13.4% median for its sector.
📉 Long-term growth concerns persist as Albemarle's three-year average annual revenue growth stands at -12.5%.
💰 The stock trades at approximately $109.47 per share as of September 16, 2026.
🔍 Market analysis indicates the decline is driven by company-specific momentum rather than broad S&P 500 weakness.
- Revenue growth over the last twelve months was 18.3%, significantly outperforming the 6.9% median for S&P 500 Materials stocks.
- The company maintains an operating margin of 13.7%, which is above the 13.4% median among its sector peers.
- The stock has declined for six consecutive trading days, resulting in a cumulative loss of 15% and erasing $2.3 billion in market value.
- The company's three-year average annual revenue growth is negative at -12.5%, indicating a lack of sustained long-term expansion.